Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Innocan Pharma Corp
(OP:
INNPF
)
0.1800
UNCHANGED
Last Price
Updated: 12:51 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.1800
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.1800
Today's Range
0.1800 - 0.1800
52wk Range
0.1800 - 0.3545
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CBD-Focused Innocan Pharma Achieves 4X Revenue Growth In Q1, Hits $6.8M Mark
May 28, 2024
Innocan Pharma's Q1 2024 revenue surged 334% to $6.8M, driven by strong sales growth from BI Sky Global. Read about financial performance.
Via
Benzinga
This Pharma Co. Kicks Off FDA Approval Process For CBD-Based Treatment Of Chronic Pain
April 23, 2024
Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of application for a Pre-IND meeting with the U.S. Food and Drug Administration...
Via
Benzinga
Exposures
Product Safety
Performance
YTD
-25.96%
-25.96%
1 Month
-5.26%
-5.26%
3 Month
-13.92%
-13.92%
6 Month
-20.32%
-20.32%
1 Year
-47.67%
-47.67%
More News
Read More
534% Revenue Surge Unveiled By Israeli CBD-Focused Pharma Company, Exceeding Expectations
April 02, 2024
Via
Benzinga
CBD-Focused Pharma Co. Innocan Reveals 433% YoY Increase In 2023 Revenue As It Pursues FDA Approval
February 13, 2024
Via
Benzinga
Exposures
Product Safety
4 CBD Stocks in the Canadian Capital Market
November 02, 2021
Via
Benzinga
Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024
December 22, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
More Cannabis Funding For FDA And Product Expansion: How This Pharma Tech Company Is Doing It
October 23, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Product Safety
CBD-Focused Pharma Co. Seeks Funding To Revolutionize Healthcare
September 21, 2023
Via
Benzinga
Innocan Pharma's Q2 2023 Reports Gross Profit Growth Driven By Robust Subsidiary Sales
August 28, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 25, 2023
August 25, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Innocan Pharma Secures $1.4M Via Private Placement
August 04, 2023
Via
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
August 21, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Innocan Pharma To Secure Up To $3M Via Private Placement Of Units At A 9% Prime Above Share Price
July 25, 2023
Via
Benzinga
Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers
August 17, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For July 21, 2023
July 21, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 14, 2023
August 14, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Innocan Pharma Q1 Revenue Grows 500%, Here Is What You Need To Know
June 01, 2023
Via
Benzinga
Cannabis Stock Gainers And Losers From August 11, 2023
August 11, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Innocan Pharma FY22 Revenue Grows 1205% To $2.6M, Here Is What You Need To Know
April 19, 2023
Via
Benzinga
Can Liposomal CBD Injection Help Dogs With Polyarthritis? Innocan Pharma Reports Clinical Success
February 21, 2023
Via
Benzinga
Innocan Pharma Q3 Revenue Grows 700% YoY, Here Is What You Need To Know
November 29, 2022
Via
Benzinga
Innocan Pharma Provides an Operational Update
September 21, 2022
Via
Newsfile
Topics
Intellectual Property
Exposures
Intellectual Property
Innocan Pharma Reports Another Successful Result from a Pre-Clinical Study on a Dog Suffering from Refractory (Drug-Resistant) Epilepsy Following LPT Treatment
September 09, 2022
Via
Newsfile
Innocan Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference on September 12-14, 2022
September 06, 2022
Via
Newsfile
Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals
September 03, 2021
Via
Newsfile
Topics
Intellectual Property
Supply Chain
Exposures
COVID-19
Intellectual Property
Supply Chain
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.